Recruiting Triple Negative Breast Cancer Studies in Columbus
Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC
This research study involves testing the safety and efficacy of an investigational intervention for patients with triple-negative breast cancer (TNBC) that has spread, or metastasized, to other parts ...
Peri-Operative Immune Checkpoint Inhibition and Cryoablation in Women With Triple-negative Breast Cancer
The purpose of this study is to determine the impact of pre-operative cryoablation, and immune checkpoint inhibition (ICI) on on 3-year Event Free Survival (EFS), in women with residual hormone recept...
About Triple Negative Breast Cancer Clinical Trials in Columbus
Triple-negative breast cancer (TNBC) lacks estrogen receptors, progesterone receptors, and excess HER2 protein, limiting targeted treatment options. It accounts for about 10-15% of breast cancers and tends to be more aggressive. Active research focuses on immunotherapy and novel drug combinations.
There are currently 2 triple negative breast cancer clinical trials recruiting participants in Columbus, GEORGIA. These studies are seeking a combined 190 participants. Research is being sponsored by Dana-Farber Cancer Institute, University of Texas Southwestern Medical Center. Clinical trial participation is free and participants receive study-related medical care at no cost.
Triple Negative Breast Cancer Clinical Trials in Columbus — FAQ
Are there triple negative breast cancer clinical trials in Columbus?
Yes, there are 2 triple negative breast cancer clinical trials currently recruiting in Columbus, GEORGIA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Columbus?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Columbus research site will contact you about next steps.
Are clinical trials in Columbus free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Columbus studies also compensate for your time and travel.
What triple negative breast cancer treatments are being tested?
The 2 active trials in Columbus are testing new therapies including novel drugs, biologics, and treatment approaches for triple negative breast cancer.
Data updated March 2, 2026 from ClinicalTrials.gov